Experimental Evaluation of Catalytic Pyrolysis Performance for Cosmetic and Medical Waste Treatment

Catalytic pyrolysis has emerged as a sustainable thermochemical solution for treating cosmetic and medical waste streams that are difficult to manage through conventional incineration or landfill disposal. Laboratory experiments that quantify pyrolysis-catalytic performance—covering feedstock characterization, product yields, oil quality, catalyst behavior, and emission control—provide the essential data required to design efficient and compliant waste-to-resource systems. This article presents a complete technical framework for the experimental evaluation of catalytic pyrolysis applied to cosmetic and medical waste, including sample preparation, testing items, analytical methods, applications, and frequently asked questions.

Technical Overview

Catalytic pyrolysis is an advanced thermal conversion process in which organic waste is decomposed in an oxygen-free or oxygen-limited atmosphere at temperatures typically between 400°C and 700°C, while the evolved vapors are passed over a solid catalyst—such as a zeolite, an alkaline-earth oxide, or a transition-metal composite—that upgrades the vapors into higher-quality liquid fuel and syngas. Cosmetic and medical waste represents one of the most challenging feedstock categories for thermal treatment, because it combines diverse polymers (polypropylene, polyethylene, PVC, PET, polyurethane), emulsified oils, surfactants, preservative and pharmaceutical residues, and, in the case of clinical waste, potential microbiological hazards.

Compared with direct incineration, catalytic pyrolysis offers several distinct advantages for this waste class: volume and mass reduction of typically 70–90%, recovery of a liquid fuel with a higher heating value (HHV) of 35–45 MJ/kg, in-situ deoxygenation and dechlorination of the vapor phase, immobilization of heavy metals within a stable solid char matrix, and suppression of dioxin formation through a reducing atmosphere combined with rapid vapor quenching. The catalyst shortens residence time, narrows the boiling-point distribution of the oil, reduces corrosive oxygenated compounds such as carboxylic acids and ketones, and enriches valuable aromatic hydrocarbons.

A rigorous experimental program is required to verify these benefits for any specific waste blend. The key performance indicators (KPIs) evaluated in a typical pyrolysis-catalytic effect experiment include:

• Product distribution: pyrolysis oil yield, aqueous fraction, gas yield, solid char and wax yields, and mass-balance closure
• Conversion efficiency and organic destruction efficiency of the overall process
• Pyrolysis oil quality: hydrocarbon composition, HHV, acid number, water content, density, and chlorine content
• Syngas quality: hydrogen, methane, carbon monoxide, carbon dioxide, and C2–C4 hydrocarbon concentrations
• Catalyst performance: deoxygenation degree, aromatization selectivity, HCl capture capacity, coking rate, and regeneration stability
• Emission performance: dioxins and furans, HCl, SO2, NOx, CO, particulate matter, and heavy metals in the flue gas
• Energy recovery ratio and microbial inactivation verification for clinical feedstocks

Testing Samples

Cosmetic Waste Streams

Cosmetic waste samples are collected from manufacturing reject batches, expired inventories, recalled products, and post-consumer packaging. Typical sample categories include:

• Expired or non-conforming formulations such as creams, lotions, serums, and sunscreens containing emulsifiers, waxes, silicones, paraben preservatives, and fragrance compounds
• Rigid and flexible plastic packaging: polypropylene caps, polyethylene and PET bottles, multi-layer laminated tubes and sachets, pump dispensers, and ABS or PMMA compact cases
• Production-line residues, tank-cleaning sludge, and wastewater-screening solids from cosmetic plants

Medical Waste Streams

Medical waste samples are collected under a documented chain of custody from healthcare facilities and are either handled within appropriate containment or pre-inactivated before laboratory processing. Representative categories include:

• Disposable clinical consumables: polypropylene syringes, polyethylene infusion bottles, and PVC intravenous bags and tubing
• Personal protective equipment: polypropylene nonwoven masks and gowns, nitrile gloves, and latex gloves
• Expired pharmaceuticals, blister packaging residues, and medicinal packaging films
• Dressings, cotton swabs, gauze, and contaminated absorbent materials

Sample Preparation and Pretreatment

All samples are segregated by category, weighed, and logged before processing. Clinical samples may be steam pre-sterilized, with inactivation verified through bioburden testing in accordance with ISO 11737-1. Samples are then dried at 105°C to constant mass, shredded to a particle size of 2–5 mm, sieved, and homogenized. For co-pyrolysis studies, blending ratios (for example, 1:1 to 3:1 polymer-to-residue by mass) are documented precisely, and prepared samples are stored in sealed desiccators to prevent moisture uptake that would distort mass balances.

Testing Items

Feedstock Characterization

• Proximate analysis: moisture, volatile matter, ash, and fixed carbon in accordance with ASTM E1131 and ISO 17246
• Ultimate analysis: carbon, hydrogen, nitrogen, sulfur, and oxygen in accordance with ASTM D5373 and ISO 16948
• Higher heating value determined by bomb calorimetry per ASTM D240, ISO 1928, or GB/T 213
• Total chlorine and sulfur content, which governs corrosion and dioxin formation risk
• Heavy metal screening (Pb, Cd, Hg, Cr, As, Ni) by ICP-OES or ICP-MS in accordance with ISO 11885 and GB 5085.3

Process Performance Indicators

• Oil yield, aqueous-phase yield, gas yield, and solid residue yield on a dry basis, with mass-balance closure within ±5%
• Overall conversion efficiency and organic destruction efficiency
• Wax fraction quantification, an indicator of insufficient cracking severity
• Energy recovery ratio calculated from the heating values and mass flows of all products relative to the feedstock and external energy input

Product Quality Items

• Pyrolysis oil composition by GC-MS, including aliphatic hydrocarbons, mono-aromatics (BTX), phenolics, acids, ketones, and nitrogen- or chlorine-containing compounds
• Pyrolysis oil HHV, water content per ASTM D6304, acid number per ASTM D664, and density per ASTM D4052
• Syngas composition (H2, CH4, CO, CO2, C2–C4) by gas chromatography per ASTM D1945, with calculated lower heating value
• Char residual carbon, ash content, HHV, BET specific surface area per ISO 9277, and leaching toxicity per GB 5085.3

Catalyst and Emission Items

• Catalyst conversion enhancement, deoxygenation degree, BTX selectivity, and HCl capture efficiency
• Coke deposition on spent catalysts and activity retention across repeated regeneration cycles
• Flue gas emissions: PCDD/PCDF per EN 1948, HCl, SO2, NOx, CO, and particulate-bound heavy metals, verified in accredited third-party laboratories where regulatory reporting is required
• Microbial inactivation verification of residues for clinical feedstocks per ISO 11737-1

Testing Methods

Thermogravimetric and Kinetic Analysis

Thermogravimetric analysis (TGA) is the first experimental step, performed under nitrogen at heating rates of 5, 10, and 20°C/min in accordance with ASTM E1131 and ISO 11358. Derivative thermogravimetric (DTG) curves identify the characteristic decomposition temperatures of each polymer and organic fraction in the waste blend. Model-free kinetic methods—Kissinger, Flynn–Wall–Ozawa, Kissinger–Akahira–Sunose, and Friedman approaches—are then applied to derive apparent activation energies, which inform reactor temperature profiles and residence time design at scale.

Bench-Scale Pyrolysis-Catalytic Experiments

The core experiments are conducted in fixed-bed or bench-scale fluidized quartz reactor systems. A typical protocol loads 5–20 g of prepared feedstock into the pyrolysis zone maintained at 400–700°C under a nitrogen carrier flow of 50–200 mL/min, with vapor residence times of 1–3 seconds. The evolved vapors pass through an independently temperature-controlled catalyst zone containing, for example, HZSM-5, HY zeolite, natural clinoptilolite, CaO, CaO–Fe2O3 composites, or spent equilibrium FCC catalyst, at catalyst-to-feed mass ratios between 0.1 and 1.0. Condensable products are captured in a chilled condenser train, non-condensable gases are collected in gas bags for chromatographic analysis, and the solid residue is recovered and weighed. Each condition is run in triplicate.

Experimental design follows a structured sequence: single-factor screening of temperature, catalyst type, catalyst ratio, and residence time, followed by response surface methodology (Box–Behnken or central composite designs) or Taguchi orthogonal arrays to identify optimal operating windows. Results are subjected to analysis of variance (ANOVA) to confirm the statistical significance of each factor and its interactions.

Catalyst Characterization

Fresh and spent catalysts are characterized by X-ray diffraction for crystalline phase integrity, nitrogen physisorption per ISO 9277 for BET surface area and pore structure, ammonia temperature-programmed desorption (NH3-TPD) for acid site density and strength, and scanning electron microscopy for morphology and coke deposition. Temperature-programmed oxidation quantifies the coke laid down during each run, and multi-cycle regeneration tests—typically five carbon burn-off and reuse cycles—establish the practical catalyst lifetime and the economics of the process.

Product and Emission Analysis

Pyrolysis oil is analyzed by GC-MS with internal standardization for compositional quantification, by simulated distillation for boiling-point distribution, and by bomb calorimetry for HHV. Water content is measured by Karl Fischer titration per ASTM D6304, acidity per ASTM D664, and organochlorine by combustion–ion chromatography. Gas composition is determined by gas chromatography with thermal conductivity and flame ionization detection per ASTM D1945. Solid char undergoes leaching toxicity evaluation per GB 5085.3 to classify it for disposal or valorization. Flue gas dioxin sampling and analysis follows EN 1948, and complete analytical packages are cross-validated by accredited third-party laboratories when required for regulatory submissions.

Applications

The data generated by pyrolysis-catalytic effect experiments directly support engineering and regulatory decision-making across the waste management and personal-care industries. Principal applications include:

• Scale-up design packages for on-site treatment units at hospitals, clinics, and cosmetic manufacturing plants, including reactor sizing, catalyst inventory, and heat-recovery specifications
• Catalyst selection, dosing optimization, and lifecycle validation for commercial pyrolysis plant operators
• Hazardous waste licensing dossiers, environmental impact assessments, and emission compliance demonstrations prepared with accredited third-party laboratory reports
• Co-pyrolysis research programs that blend cosmetic or medical waste with biomass, waste plastics, or sludge to balance hydrogen and oxygen availability
• Char valorization studies, converting solid residues into activated carbon adsorbents or supplementary solid fuels after leaching compliance is demonstrated
• Fuel oil quality assessment for blending into industrial boilers and cement kilns as a substitute fossil fuel
• Academic and industrial research on aromatics recovery, hydrogen-rich syngas production, and chlorine management in mixed clinical polymers

FAQ

What is the optimal temperature range for catalytic pyrolysis of cosmetic and medical waste?

For mixed cosmetic and medical polymer waste, most experiments identify an optimum pyrolysis zone temperature of 500–550°C with a catalyst zone maintained at 400–500°C. Lower temperatures leave excessive wax and unconverted residue, while higher temperatures shift the product slate from oil toward non-condensable gas and increase aromatic condensation and catalyst coking.

Does catalytic pyrolysis reliably destroy pathogens in medical waste?

Yes. Oxygen-free thermal treatment above 400°C with adequate residence time destroys vegetative bacteria, bacterial spores, fungi, and viruses by complete organic decomposition. Sterility and inactivation are confirmed experimentally through bioburden testing of the residues in accordance with ISO 11737-1, and clinical feedstocks are additionally managed under documented containment and chain-of-custody procedures during handling.

How do catalysts improve pyrolysis oil quality?

Zeolite catalysts such as HZSM-5 provide strong Brønsted acidity that cracks long-chain oxygenates, promotes deoxygenation to water and CO2, and drives aromatization toward BTX compounds, thereby raising heating value and chemical stability while lowering acid number. Basic oxides such as CaO neutralize acidic species and capture HCl and CO2, protecting downstream equipment and reducing chlorine carryover into the oil.

How is chlorine from PVC medical devices controlled?

PVC in IV bags and tubing releases HCl during decomposition and raises the risk of organochlorine formation. Mitigation measures verified in the experiments include alkaline-earth and iron-based sorbent beds achieving HCl capture efficiencies above 90%, operation under a reducing atmosphere that suppresses chlorine oxidation, and rapid vapor quenching through the 250–450°C window within 1–2 seconds to prevent de-novo dioxin reformation, with final verification per EN 1948.

Which standards govern the evaluation program?

The experimental framework references ISO standards (ISO 11737-1, ISO 9277, ISO 11358, ISO 11885, ISO 16948, ISO 17246, ISO 1928), ASTM standards (ASTM E1131, D240, D4052, D5373, D6304, D664, D1945), EN 1948 for dioxin emissions, and GB/T 213 and GB 5085.3 for heating value and leaching toxicity classification. Comprehensive verification is performed by accredited third-party laboratories where regulatory acceptance is required.

Can the pyrolysis char be safely reused?

Char can be valorized as a solid fuel, soil amendment precursor, or feedstock for activated carbon production, provided it passes the leaching toxicity criteria of GB 5085.3 and meets the heavy metal limits applicable to its intended use. Experimental programs routinely include surface area, elemental, and leaching characterization of the char to establish its compliance pathway before any reuse claim is made.

How is catalyst deactivation managed over long-term operation?

The dominant deactivation mechanism is coke deposition on acid sites, followed by possible poisoning by chlorine and nitrogen species. Experiments quantify coke by temperature-programmed oxidation and track activity over at least five regeneration cycles using controlled carbon burn-off. Process countermeasures include optimizing catalyst-to-feed ratio, staging fresh catalyst make-up, and positioning chlorine sorbents upstream of the zeolite bed to extend catalyst life.